Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Oct;34(10):1308-1313.
doi: 10.1089/thy.2024.0224. Epub 2024 Aug 27.

TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer

Julio C Ricarte-Filho  1 , Erin R Reichenberger  2 , Kyle Hinkle  1 , Amber Isaza  1 , Andrew J Bauer  1 , Aime T Franco  1   3
Affiliations
Case Reports

TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer

Julio C Ricarte-Filho et al. Thyroid. 2024 Oct.

Abstract

Background: Receptor tyrosine kinase (RTK) fusions of RET, NTRK1/3, and ALK are enriched among pediatric thyroid cancer patients with metastatic and persistent disease, and their oncoproteins represent attractive drug targets. Methods: We performed RNA-sequencing in a papillary thyroid cancer (PTC) lacking other frequent driver alterations. Results: We report a novel RTK fusion, TG-insulin-like growth factor 1 receptor gene (IGF1R), in a 17-year-old female patient with angioinvasive follicular variant PTC. The in-frame fusion protein preserves the cholinesterase-like domain of TG with dimerization properties and the transmembrane and kinase domain of IGF1R. The tumor sample shows increased IGF1R mRNA expression and tyrosine kinase phosphorylation, augmentation of Mitogen activated protein kinase (MAPK) transcriptional output genes, and decreased NIS levels. Conclusions: We reveal a novel targetable kinase fusion oncogene in thyroid cancer which is not incorporated in different thyroid-specific sequencing panels. The integration of IGF1R fusion screening in the next versions of thyroid-specific targeted next-generation sequencing panels may be beneficial to thyroid cancer patients.

Keywords: IGF1R; RNA-sequencing; fusion; pediatric; thyroid cancer.

PubMed Disclaimer

References

    1. Pekova B, Sykorova V, Dvorakova S, et al. . RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas. Thyroid 2020;30(12):1771–1780; doi: 10.1089/thy.2019.0802 - DOI - PubMed
    1. Stosic A, Fuligni F, Anderson ND, et al. . Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma. Cancer Res 2021;81(22):5625–5637; doi: 10.1158/0008-5472.CAN-21-0761 - DOI - PubMed
    1. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000;103(2):211–225; doi: 10.1016/s0092-8674(00)00114-8 - DOI - PubMed
    1. Franco AT, Ricarte-Filho JC, Isaza A, et al. . Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers. J Clin Oncol 2022;40(10):1081–1090; doi: 10.1200/JCO.21.01861 - DOI - PMC - PubMed
    1. Ho AL, Grewal RK, Leboeuf R, et al. . Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N Engl J Med 2013;368(7):623–632; doi: 10.1056/NEJMoa1209288 - DOI - PMC - PubMed

Publication types

LinkOut - more resources